Clinical Trial Update: Effect of Bosentan on Skin Fibrosis in Patients With Systemic Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bosentan for skin fibrosis in systemic sclerosis has completed; the update notes the study status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• Bosentan (Bosentan)

Snippet

Sponsor: Heinrich-Heine University, Duesseldorf | Conditions: Systemic Scleroderma, Skin Fibrosis | Phase 2 | Status: COMPLETED